DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Talpaz M, Kiladjian JJ.
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis.
Leukemia 2021;
35 (01) 1-17
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.